Update To The Hidden Hand: Big Pharma’s Influence On “Patient Advocacy Groups” Shows Industry’s Control Of The Haystack Project, No Patient Left Behind, And The Community Oncology Alliance
New Analysis Shows How The New Law Will Provide Average Savings of $7,590 To Some Cancer Patients With Medicare And Specifically To People Taking Seven High-Priced Cancer Drugs
“It’s Time For The Other Big Insulin Corporations To Follow Suit”
Patient Advocate Lisa Ann Wetzel-Trainor Moderated A Conversation Where Merith Answered Questions On Her Background, The Inflation Reduction Act, And P4AD’s Future Goals:
The following statement was issued by David Mitchell, a cancer patient and founder and president of Patients For Affordable Drugs, in response to the pricing of Relyvrio following the Food and Drug Administration’s approval of the drug combination to treat amyotrophic lateral sclerosis (ALS):
Basey Has Devoted Her Career To Ensuring That Life-saving Medications Are Affordable And Accessible For All Who Need Them
In The Third Year Of The Pandemic And As Americans Grapple With Record Inflation, Big Pharma Continues To Raise Prices And Exploit Patients
A new report issued today documents how drug companies use their market and political power to avoid competition and raise prices in lockstep.
Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.
